Format

Send to

Choose Destination
Cell Stem Cell. 2018 Feb 1;22(2):153-156. doi: 10.1016/j.stem.2018.01.001.

Japan Strengthens Regenerative Medicine Oversight.

Author information

1
Keio University School of Medicine, Department of Physiology, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan; Keio University Global Research Institute, 2-15-45 Mita, Minato-ku, Tokyo 108-8345, Japan; RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Chuo-ku, Kobe 650-0047, Japan; RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Building, 15th floor, 1-4-1 Nihonbashi, Chuo-ku, Tokyo 103-0027, Japan.
2
Keio University School of Medicine, Department of Physiology, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan; Keio University Global Research Institute, 2-15-45 Mita, Minato-ku, Tokyo 108-8345, Japan. Electronic address: hidokano@a2.keio.jp.

Abstract

The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.

PMID:
29395052
DOI:
10.1016/j.stem.2018.01.001

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center